Thrombosis
Clinical
DOACs for treatment of cancer-associated venous thromboembolism
Recent studies suggest DOACs may be a viable option in the treatment of malignancy-associated VTE.
News
ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding
LOS ANGELES – Use of novel oral anticoagulants may be preferred over vitamin K antagonists in patients with diabetes and AFib.
News
New ASH guideline: VTE prophylaxis after major surgery
ORLANDO – The chair of VTE guidelines panel presented highlights of the latest guidelines in a special session at the annual meeting of the...
News
Aspirin plus a DOAC may do more harm than good in some
Adding aspirin to DOAC therapy for the secondary prevention of VTE or the prevention of stroke associated with NVAF without a clear indication...
News
Pulmonary embolism treatment teams adopted widely for complex disease
News
Smokers with PE have higher rate of hospital readmission
NEW ORLEANS – The rate of readmission within 30 days was significantly higher among PE patients with tobacco...
Clinical
Aspirin for primary prevention reduces risk of CV events, increases bleeding
What is the association between aspirin for primary prevention and cardiovascular events and bleeding?
All Content
Patient-reported complications regarding PICC lines after inpatient discharge
What signs and symptoms of possible complications are observed in patients who undergo placement of a peripherally inserted central catheter (PICC...
Clinical
How should anticoagulation be managed in a patient with cirrhosis?
Patients with chronic liver disease have a risk of VTE similar to (or even greater than) that of general medical patients.
News
FDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patients
The latest approval is based on results from the phase 3 MAGELLAN and MARINER trials, which included more than 20,000 patients.